b-Arrestins in the Central Nervous System - Progress in Molecular Biology and Translational Science - page 284

114. Callado LF, Meana JJ, Grijalba B, Pazos A, Sastre M, Garcia-Sevilla JA. Selective
increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide
victims. J Neurochem . 1998;70(3):1114- 1123.
115. Garcia-Sevilla JA, Escriba PV, Ozaita A, et al. Up-regulation of immunolabeled
alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the
prefrontal cortex of depressed suicides. J Neurochem . 1999;72(1):282- 291.
116. Ordway GA, Schenk J, Stockmeier CA, May W, Klimek V. Elevated agonist binding
to alpha2-adrenoceptors in the locus coeruleus in major depression. Biol Psychiatry .
2003;53(4):315- 323.
117. Escriba PV, Ozaita A, Garcia-Sevilla JA. Increased mRNA expression of alpha2A-
adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide
victims. Neuropsychopharmacology . 2004;29(8):1512- 1521.
118. Eason MG, Liggett SB. Subtype-selective desensitization of alpha 2-adrenergic recep-
tors. Different mechanisms control short and long term agonist-promoted desensitiza-
tion of alpha 2C10, alpha 2C4, and alpha 2C2. J Biol Chem . 1992;267

(35):25473 - 25479.
119. Kurose H, Lefkowitz RJ. Differential desensitization and phosphorylation of three
cloned and transfected alpha 2-adrenergic receptor subtypes. J Biol Chem . 1994;269
(13):10093 - 10099.
120. Jewell-Motz EA, Liggett SB. G protein-coupled receptor kinase specificity for phos-
phorylation and desensitization of alpha2-adrenergic receptor subtypes. J Biol Chem .
1996;271(30):18082 - 18087.
121. Small KM, Schwarb MR, Glinka C, et al. Alpha2A- and alpha2C-adrenergic receptors
form homo- and heterodimers: the heterodimeric state impairs agonist-promoted
GRK phosphorylation and beta-arrestin recruitment. Biochemistry . 2006;45

(15):4760- 4767.
122. Cottingham C, Chen Y, Jiao K, Wang Q, et al. The antidepressant desipramine is an
arrestin-biased ligand at the alpha(2A)-adrenergic receptor driving receptor down-
regulation in vitro and in vivo. J Biol Chem . 2011;286(41):36063- 36075.
123. Hara MR, Kovacs JJ, Whalen EJ, et al. A stress response pathway regulates DNA damage
through beta2-adrenoreceptors and beta-arrestin-1. Nature . 2011;477(7364):349- 353.
124. Wang Q, Zhao J, Brady AE, et al. Spinophilin blocks arrestin actions in vitro and
in vivo at G protein-coupled receptors. Science . 2004;304(5679):1940 - 1944.
125. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. Enhanced
morphine analgesia in mice lacking beta-arrestin 2. Science . 1999;286

(5449):2495- 2498.
126. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. Mu-opioid receptor
desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.
Nature . 2000;408(6813):720- 723.
127. Raehal KM, Walker JK, Bohn LM. Morphine side effects in beta-arrestin 2 knockout
mice. J Pharmacol Exp Ther . 2005;314(3):1195- 1201.
128. Heinricher MM, McGaraughty S, Farr DA. The role of excitatory amino acid trans-
mission within the rostral ventromedial medulla in the antinociceptive actions of sys-
temically administered morphine. Pain . 1999;81(1- 2):57 - 65.
129. Kieffer BL, Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog
Neurobiol . 2002;66(5):285- 306.
130. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ. beta-Arrestin 1 and 2 dif-
ferentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci
USA . 2001;98(4):1601- 1606.
131. Bohn LM, Lefkowitz RJ, Caron MG. Differential mechanisms of morphine anti-
nociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.

J Neurosci .

2002;22(23):10494- 10500.